Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Iomai Announces Second Quarter 2007 Financial Results and Business Progress
August 27th, 2007
Iomai Corporation (NASDAQ:IOMI) reported financial results and corporate progress for the second quarter ended June 30, 2007. "This quarter was marked by a series of important clinical findings about our patch-based vaccines for travelers' diarrhea and influenza. Particularly notable was an announcement earlier this month of remarkable results from the Phase 2 field study of our travelers' diarrhea vaccine, which found that the Iomai patch cut the risk of moderate and severe diarrhea by 75 percent in travelers, a statistically significant result," said Stanley C. Erck, President and Chief Executive Officer of Iomai. "With these new clinical data in hand, we will focus...
Source: Clinical Trials Week (2007-08-27)
|
